OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current and emerging therapies for neuroendocrine prostate cancer
Busola R. Alabi, Shiqin Liu, Tanya Stoyanova
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108255-108255
Closed Access | Times Cited: 38
Busola R. Alabi, Shiqin Liu, Tanya Stoyanova
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108255-108255
Closed Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
Shiqin Liu, Timothy Chai, Fernando Jose Garcia-Marques, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101381-101381
Open Access | Times Cited: 15
Shiqin Liu, Timothy Chai, Fernando Jose Garcia-Marques, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101381-101381
Open Access | Times Cited: 15
Cell Membrane‐Camouflaged Chitosan‐Polypyrrole Nanogels Co‐Deliver Drug and Gene for Targeted Chemotherapy and Bone Metastasis Inhibition of Prostate Cancer
Qiuyu Yu, Yue Gao, Waicong Dai, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 12
Qiuyu Yu, Yue Gao, Waicong Dai, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 12
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer
Honghu Zhang, Lin Qi, Yi Cai, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 5
Honghu Zhang, Lin Qi, Yi Cai, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 5
The Current Therapeutic Landscape for Metastatic Prostate Cancer
A. Gómez Bernal, Alivia Bechler, Kabhilan Mohan, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 351-351
Open Access | Times Cited: 5
A. Gómez Bernal, Alivia Bechler, Kabhilan Mohan, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 351-351
Open Access | Times Cited: 5
Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution
Kira Furlano, Tina Keshavarzian, Nadine Biernath, et al.
International Journal of Cancer (2025)
Open Access
Kira Furlano, Tina Keshavarzian, Nadine Biernath, et al.
International Journal of Cancer (2025)
Open Access
Novel hormone therapies for advanced prostate cancer: understanding and countering drug resistance
Zhipeng Wang, Jie Wang, Dengxiong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101232-101232
Open Access
Zhipeng Wang, Jie Wang, Dengxiong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101232-101232
Open Access
MTHFD2 in healthy and cancer cells: Canonical and non-canonical functions
Natalia Pardo‐Lorente, Sara Sdelci
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 4
Natalia Pardo‐Lorente, Sara Sdelci
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 4
Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons
Ross Liao, Hui Ting Ruan, Albert Jang, et al.
American Society of Clinical Oncology Educational Book (2024), Iss. 44
Open Access | Times Cited: 3
Ross Liao, Hui Ting Ruan, Albert Jang, et al.
American Society of Clinical Oncology Educational Book (2024), Iss. 44
Open Access | Times Cited: 3
Unveiling the latest insights into Androgen Receptors in Prostate Cancer
Suleiman Zakari
International journal of medical biochemistry/International journal of medical biochemistry : (2024), pp. 101-113
Open Access | Times Cited: 3
Suleiman Zakari
International journal of medical biochemistry/International journal of medical biochemistry : (2024), pp. 101-113
Open Access | Times Cited: 3
Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach
Ilaria Granata, Paola Barboro
Biomolecules (2024) Vol. 14, Iss. 1, pp. 87-87
Open Access | Times Cited: 2
Ilaria Granata, Paola Barboro
Biomolecules (2024) Vol. 14, Iss. 1, pp. 87-87
Open Access | Times Cited: 2
Prognostic nomogram to predict cancer-specific survival with small-cell carcinoma of the prostate: a multi-institutional study
Yupeng Di, Jiazhao Song, Zhuo Song, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Yupeng Di, Jiazhao Song, Zhuo Song, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity
Giarita Ferraro, Vanessa Sanfilippo, Lorenzo Chiaverini, et al.
Dalton Transactions (2023) Vol. 52, Iss. 26, pp. 9058-9067
Open Access | Times Cited: 7
Giarita Ferraro, Vanessa Sanfilippo, Lorenzo Chiaverini, et al.
Dalton Transactions (2023) Vol. 52, Iss. 26, pp. 9058-9067
Open Access | Times Cited: 7
Immunomodulatory Role of Thioredoxin Interacting Protein in Cancer’s Impediments: Current Understanding and Therapeutic Implications
Ramkumar Katturajan, Sangeetha Nithiyanandam, Manisha Parthasarathy, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1902-1902
Open Access | Times Cited: 10
Ramkumar Katturajan, Sangeetha Nithiyanandam, Manisha Parthasarathy, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1902-1902
Open Access | Times Cited: 10
Dual-source powered nanomotors coupled with dual-targeting ligands for efficient capture and detection of CTCs in whole blood and in vivo tumor imaging
Jiaoyu Ren, Zekun Chen, Enhui Ma, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 231, pp. 113568-113568
Closed Access | Times Cited: 5
Jiaoyu Ren, Zekun Chen, Enhui Ma, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 231, pp. 113568-113568
Closed Access | Times Cited: 5
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer
Daniel J. Turnham, Manisha S. Mullen, Nicholas Bullock, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 673-673
Open Access | Times Cited: 1
Daniel J. Turnham, Manisha S. Mullen, Nicholas Bullock, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 673-673
Open Access | Times Cited: 1
From biology to the clinic — exploring liver metastasis in prostate cancer
Xudong Ni, Wei Yu, Xiaomeng Li, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 10, pp. 593-614
Closed Access | Times Cited: 1
Xudong Ni, Wei Yu, Xiaomeng Li, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 10, pp. 593-614
Closed Access | Times Cited: 1
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate
Haley Meyer, Rajitha Sunkara, Emily Rothmann, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 5, pp. 102172-102172
Closed Access | Times Cited: 1
Haley Meyer, Rajitha Sunkara, Emily Rothmann, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 5, pp. 102172-102172
Closed Access | Times Cited: 1
Recent insights on the clinical, pathological, and molecular features of intraductal carcinoma of the prostate
Yushi Naito, Masashi Kato, Jun Nagayama, et al.
International Journal of Urology (2023) Vol. 31, Iss. 1, pp. 7-16
Open Access | Times Cited: 4
Yushi Naito, Masashi Kato, Jun Nagayama, et al.
International Journal of Urology (2023) Vol. 31, Iss. 1, pp. 7-16
Open Access | Times Cited: 4
Loss of ERRγ promotes lineage plasticity towards neuroendocrine prostate cancer
Vincent Giguère, Ting Li, Catherine R. Dufour, et al.
Research Square (Research Square) (2024)
Open Access
Vincent Giguère, Ting Li, Catherine R. Dufour, et al.
Research Square (Research Square) (2024)
Open Access
Lethal disseminated intravascular coagulation induced by primary and metastatic neuroendocrine prostate cancer
Takashi Ando, Taro Sasaki, Makoto Naito
IJU Case Reports (2024) Vol. 7, Iss. 3, pp. 238-242
Open Access
Takashi Ando, Taro Sasaki, Makoto Naito
IJU Case Reports (2024) Vol. 7, Iss. 3, pp. 238-242
Open Access
A Review of the Evolving Role of Radiotherapy in the Treatment of Neuroendocrine Neoplasms
Ling Fung Nelson Yit, You‐Quan Li
Neuroendocrinology (2024) Vol. 114, Iss. 9, pp. 856-865
Open Access
Ling Fung Nelson Yit, You‐Quan Li
Neuroendocrinology (2024) Vol. 114, Iss. 9, pp. 856-865
Open Access
Assessment of Anti-Prostate Cancer Activity among Four Seaweeds, with Focus on Caulerpa lentillifera J.Agardh
Guan-James Wu, Pei‐Wen Hsiao
Foods (2024) Vol. 13, Iss. 9, pp. 1411-1411
Open Access
Guan-James Wu, Pei‐Wen Hsiao
Foods (2024) Vol. 13, Iss. 9, pp. 1411-1411
Open Access
Understanding the molecular regulators of neuroendocrine prostate cancer
Sreyashi Bhattacharya, Avery Stillahn, Kaitlin Smith, et al.
Advances in cancer research (2024), pp. 403-429
Closed Access
Sreyashi Bhattacharya, Avery Stillahn, Kaitlin Smith, et al.
Advances in cancer research (2024), pp. 403-429
Closed Access
Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer
Weijie Zhang, Adam M. Lee, L.J. Lee, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 9
Open Access
Weijie Zhang, Adam M. Lee, L.J. Lee, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 9
Open Access
Structural Optimization of Isoquinoline Derivatives from Lycobetaine and Their Inhibitory Activity against Neuroendocrine Prostate Cancer Cells
Zhuo Zhang, Qianqian Shen, Yiyi Ji, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4503-4503
Open Access
Zhuo Zhang, Qianqian Shen, Yiyi Ji, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4503-4503
Open Access
